Dr. NK Arora, Chairman of the NTAGI Covid-19 Working Group, stated on Tuesday (February 15) that the Covid-19 vaccine Corbevax is a safe vaccine that will be administered in two doses like other vaccines.
“Corbevax is a safe vaccine and local reactions are also less. The antibody level of this vaccine is also very high. Overall Corbevax is a very useful vaccine. It will have 2 primary doses just like other vaccines in India,” told Dr Arora to ANI.
This comes after India`s apex drug regulatory body Drugs Controller General of India`s Subject Expert Committee on Monday (February 14) granted the restricted emergency use authorisation to Biological E`s Covid vaccine Corbevax for adolescents in the 12 to 18 years age bracket. However, the approval is subject to certain conditions, said a source familiar with the development.
